DNTH — Dianthus Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.17bn
- $3.28bn
- $2.04m
Brief: Dianthus Therapeutics Says Selling Stockholders Are Offering On Resale Basis Of Up To 23.7 Million Shares Of Common Stock Of Co
Brief: Dianthus Therapeutics Files For Resale Of Up To 23.7 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
U.S. RESEARCH ROUNDUP-Duolingo, Nova, Universal Health Services
Dianthus Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Dianthus Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview
Dianthus Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Dianthus Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule
U.S. RESEARCH ROUNDUP-Darden Restaurants, Fedex, Nike
Dianthus Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Dianthus Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis
Brief: Dianthus Therapeutics Inc Files Prospectus, Selling Stockholders Offering On Resale Basis Up To 5.46 Million Shares Of Common Stock
Brief: RA Capital Management Reports 9.99% Passive Stake In Dianthus Therapeutics
Brief: Dianthus Therapeutics Announces $230 Million Private Placement
Dianthus Therapeutics Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Dianthus Therapeutics Files For Shelf Of Up To 5.5 Mln Shares By Selling Stockholders - SEC Filing
Brief: Magenta Therapeutics Announces Completion Of Merger With Dianthus Therapeutics And Implementation Of Reverse Stock Split
Magenta Therapeutics Inc reports results for the quarter ended in June - Earnings Summary